As the Horizon acquisition reaps its benefits, Amgen is now turning eyes to its obesity and diabetes portfolio.

Evenity (romosozumab-aqqg) is a brand-name injection prescribed for postmenopausal osteoporosis in people with a high risk of fracture. As with other drugs, Evenity can cause side effects ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Until now, the main options for women in this category have been UCB's Evenity (romosozumab) or Eli Lilly's Forsteo (teriparatide), with older generic bisphosphonates such as alendronic acid used ...

The move – which comes after an agreement by UCB to reduce the price of the drug – makes Evenity (romosozumab) the first novel therapy for the bone-wasting condition to be available to the NHS ...

Evenity, also known as Romosozumab, can only be prescribed in hospital and around 125 Southmead Hospital patients are prescribed it each year. The drug can be self-injected with a type of EpiPen ...

Prolia (denosumab) and Evenity (romosozumab) are two monoclonal antibodies used to treat osteoporosis. Lucentis (ranibizumab) and Zaltrap (aflibercept) are two examples used to treat eye problems such ...

Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

THOUSAND OAKS, Calif., Oct. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2024.

Savvy Senior, P.O. Box 5443, Norman, OK 73070, or visit SavvySenior.org. Jim Miller is a contributor to the NBC Today show and author of “The Savvy Senior” book.